EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Emerging roles for histone deacetylases in age-related muscle atrophy

Michael E Walsh, Holly Van Remmen

Nutrition and Healthy Aging · 2016

DOI: 10.3233/nha-160005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrition and Healthy Aging, 2016. Verfasst von Michael E Walsh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Energy Metabolism Laboratory, Swiss Federal Institute of Technology (ETH) Zurich , Zurich, Switzerland. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Skeletal muscle atrophy during aging, a process known as sarcopenia, is associated with muscle weakness, frailty, and the loss of independence in older adults. The mechanisms contributing to sarcopenia are not totally understood, but muscle fiber loss due to apoptosis, reduced stimulation of anabolic pathways, activation of catabolic pathways, denervation, and altered metabolism have been observed in muscle from old rodents and humans. OBJECTIVE: Recently, histone deacetylases (HDACs) have been implicated in muscle atrophy and dysfunction due to denervation, muscular dystrophy, and disuse, and HDACs play key roles in regulating metabolism in skeletal muscle. In this review, we will discuss the role of HDACs in muscle atrophy and the potential of HDAC inhibitors for the treatment of sarcopenia. CONCLUSIONS: Several HDAC isoforms are potential targets for intervention in sarcopenia. Inhibition of HDAC1 prevents muscle atrophy due to nutrient deprivation. HDAC3 regulates metabolism in skeletal muscle and may inhibit oxidative metabolism during aging. HDAC4 and HDAC5 have been implicated in muscle atrophy due to denervation, a process implicated in sarcopenia. HDAC inhibitors are already in use in the clinic, and there is promise in targeting HDACs for the treatment of sarcopenia.

Schlagwörter

Stichwörter der Autor:innen

Agingepigeneticshistone deacetylasessarcopenia

Autor:innen und Institutionen

  • Energy Metabolism Laboratory, Swiss Federal Institute of Technology (ETH) Zurich , Zurich, Switzerland.
  • Oklahoma Medical Research Foundation , Oklahoma City, OK, USA.

Förderung

  • BLRD VA

Zitieren

APA

Walsh, M. E., & Van Remmen, H. (2016). Emerging roles for histone deacetylases in age-related muscle atrophy. Nutrition and Healthy Aging. https://doi.org/10.3233/nha-160005

Vancouver

Walsh ME, Van Remmen H. Emerging roles for histone deacetylases in age-related muscle atrophy. Nutrition and Healthy Aging. 2016. doi:10.3233/nha-160005

BibTeX
@article{Walsh2016,
  author = {Walsh, Michael E and Van Remmen, Holly},
  title = {Emerging roles for histone deacetylases in age-related muscle atrophy},
  journal = {Nutrition and Healthy Aging},
  year = {2016},
  doi = {10.3233/nha-160005}
}
Kostenlos starten →